文献速递食管胃疾病与幽门螺杆菌

幽门螺杆菌治疗与未来艰难梭菌感染无关

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

该回顾性队列研究纳入38535例检测出幽门螺杆菌的患者,评估根治治疗与3个月内艰难梭菌感染(CDI)的关联。多因素分析显示,幽门螺杆菌治疗及根除确认均与CDI无关,而既往CDI和近期出院是CDI的强相关因素。

要点

  • 幽门螺杆菌治疗不增加未来3个月内艰难梭菌感染风险。
  • 根除确认与CDI无关(OR 1.49;95%CI 0.67-3.29)。
  • 既往CDI(OR 12.5)和近期出院是CDI强相关因素。

核心结论

  • 在大型美国幽门螺杆菌患者队列中,幽门螺杆菌治疗或根除均与艰难梭菌感染无关。

研究设计与样本

  • 退伍军人健康管理局内回顾性队列研究,纳入1994年1月1日至2018年12月31日检测出幽门螺杆菌的38535例患者(中位年龄61.8岁;91.8%男性)。

主要发现

  • 38535例患者中28818例(74.8%)接受幽门螺杆菌治疗,284例(0.74%)发生CDI。
  • 多因素分析中,12周内出院(OR 2.15;95%CI 1.22-3.77)和4周内出院(OR 3.46;95%CI 2.18-5.48),P<0.001,以及既往CDI(OR 12.5;95%CI 9.21-17.0,P<0.001)为显著因素。
  • 幽门螺杆菌治疗与未来CDI无关;治疗者中根除确认与未来CDI无关(OR 1.49;95%CI 0.67-3.29)。

临床怎么用

  • 检测出幽门螺杆菌时,应继续按指征处方根除治疗,无需因CDI风险而犹豫。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Helicobacter pylori (HP) infection is associated with many gastrointestinal disorders, including gastric cancer, and consensus guidelines recommend eradication after detection. There is a theoretical, yet uninvestigated, concern that HP treatment could increase the risk of Clostridium difficile infection (CDI). Using the data from a large cohort of patients with HP, we investigated whether HP eradication is associated with CDI. METHODS: A retrospective cohort study within the Veterans Health Administration on 38,535 patients (median age 61.8 years; 91.8% men) with detected HP between January 1, 1994, and December 31, 2018 was conducted. Primary outcome was a positive laboratory test for CDI within 3 months of HP detection. Multivariable logistic regression evaluated the following: patient demographics, previous CDI, recent hospitalization, and whether the patient received HP eradication therapy (by antibiotic and regimen, and including proton pump therapy). Secondary analysis of those treated evaluated whether eradication of HP was associated with CDI. RESULTS: Among 38,535 patients, 28,818 (74.8%) were treated for HP and 284 (0.74%) developed CDI. In multivariable analysis, prominent factors included hospital discharge within 12 weeks (odds ratio [OR] 2.15; 95% confidence interval [CI]: 1.22-3.77) and 4 weeks (OR 3.46; 95% CI: 2.18-5.48), P < 0.001, and previous CDI (OR 12.5; 95% CI: 9.21-17.0, P < 0.001). Treatment of HP was not associated with future CDI. In secondary analysis of those treated, confirmation of eradication was not associated with future CDI (OR 1.49; 95% CI: 0.67-3.29). DISCUSSION: In a large study of US patients with HP, we demonstrate that neither treatment nor eradication of HP is associated with CDI. Previous C. difficile infection and recent hospital discharge, established risk factors for CDI, are strongly associated. These findings suggest that treatment should be continued to be prescribed when HP is detected (http://links.lww.com/AJG/B507).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kumar S, Metz DC, Kaplan DE, et al. Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection. Am J Gastroenterol. 2020. PMID: 32356953. doi:10.14309/ajg.0000000000000626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。